Professional Seasonal Analysis for Trading

Acumen Pharmaceuticals, Inc. - Common Stock (ABOS)

Seasonality Analysis

Stocks 5 Years Analyzed

Acumen Pharmaceuticals, Inc. - Common Stock Annual Seasonality Statistics

-0.68%
Avg Annual Return
42.9%
Avg Monthly Win Rate
5/12
Positive Months
5
Years Analyzed

Acumen Pharmaceuticals, Inc. - Common Stock Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January -2.81%
40%
Weak
February 7.33%
60%
Moderate
March WORST -20.81%
0%
Very Weak
April -4.73%
40%
Weak
May -0.31%
25%
Very Weak
June 10.98%
50%
Weak
July BEST 21.24%
80%
Very Strong
August -0.07%
60%
Weak
September 9.10%
60%
Moderate
October -9.22%
40%
Weak
November -13.60%
20%
Very Weak
December 2.22%
40%
Weak

Acumen Pharmaceuticals, Inc. - Common Stock 2026 vs Historical Pattern

Current Position
58.18
Historical Avg Position
28.11
Deviation
+30.07
Performance
Significantly Above Average

Acumen Pharmaceuticals, Inc. - Common Stock Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for ABOS with overlay patterns, custom date ranges, and more.

Create Free Account

Acumen Pharmaceuticals, Inc. - Common Stock Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

Acumen Pharmaceuticals, Inc. - Common Stock Seasonal Historical Performance

Historical Performance

See historical average returns for ABOS across multiple timeframes.

Create Free Account

About Acumen Pharmaceuticals, Inc. - Common Stock (ABOS) Seasonality

Acumen Pharmaceuticals, Inc. - Common Stock (ABOS) has been analyzed using 5 years of historical data to identify seasonal patterns. Classified under Stocks, Acumen Pharmaceuticals, Inc. - Common Stock shows distinct seasonal tendencies based on historical data.

The strongest month for Acumen Pharmaceuticals, Inc. - Common Stock is historically July, with an average return of 21.24% and a win rate of 80%. Conversely, March tends to be the weakest month, averaging -20.81% return.

Looking at the full calendar year, Acumen Pharmaceuticals, Inc. - Common Stock has an average annual return of -0.68% with an overall monthly win rate of 42.9%. Out of 12 months, 5 typically show positive average returns.

The seasonal pattern for Acumen Pharmaceuticals, Inc. - Common Stock has a consistency score of 58.5 (Fair), based on 6 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

Acumen Pharmaceuticals, Inc. - Common Stock Seasonality FAQ

What is the best month to buy Acumen Pharmaceuticals, Inc. - Common Stock (ABOS)?

Historically, July has been the best month for Acumen Pharmaceuticals, Inc. - Common Stock, with an average return of 21.24% and a win rate of 80%. However, past performance does not guarantee future results.

What is the worst month for Acumen Pharmaceuticals, Inc. - Common Stock (ABOS)?

Based on historical data, March has been the weakest month for Acumen Pharmaceuticals, Inc. - Common Stock, with an average return of -20.81%. This is a historical observation and does not guarantee future results.

How reliable is ABOS seasonality data?

The seasonality analysis for Acumen Pharmaceuticals, Inc. - Common Stock is based on 5 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use Acumen Pharmaceuticals, Inc. - Common Stock seasonality in my trading?

Use Acumen Pharmaceuticals, Inc. - Common Stock (ABOS) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.